Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine
This study is ongoing, but not recruiting participants.
Study NCT00460759   Information provided by Johns Hopkins University
First Received: April 12, 2007   Last Updated: July 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mycobacterium Tuberculosis
Additional conditions recognized in this trial
Mycobacterium Infections
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Interventions listed in this trial
Moxifloxacin
Rifapentine
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antitubercular Agents
Leprostatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Johns Hopkins University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services